Urovalve files patent for new universal catheter-inserter

NewsGuard 100/100 Score

Urovalve announced today that the Company has filed a patent to protect its new product offering in development that facilitates insertion of catheters, such as a Foley catheter. The new Urovalve device is novel because it is designed not only to add sufficient rigidity to a variety of commonly used catheters—thereby enabling their insertion when penetration would otherwise be difficult—but also still allowing these catheters to remain flexible enough to negotiate the curves of the urethra.

“Our newest device, a universal catheter-inserter, is designed to enhance placement of the desired catheter in one single step, compared to the successive dilations, etc., currently associated with difficult Foley catheter insertions,” said Harvey D. Homan, Ph.D., President and CEO of Urovalve. “This innovative approach is not only expected to save time for the patient and his urologist or other healthcare professional, but also to enable selection of the most appropriate or the most comfortable catheter, compared to opting for a catheter only because it is stiff enough to be inserted.

“Our new device’s design also includes locking mechanisms to keep it captured within the catheter throughout the insertion procedure,” added Dr. Homan. “This should provide increased control for the healthcare professional, as well as significantly reduce the risk of trauma to the patient.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experts recommend shortening the blanking period after atrial fibrillation ablation